Sareum (LON:SAR) Share Price Passes Below 200-Day Moving Average of $119.84

Sareum Holdings plc (LON:SARGet Rating) shares crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 119.84 ($1.46) and traded as low as GBX 85 ($1.04). Sareum shares last traded at GBX 97.50 ($1.19), with a volume of 148,819 shares changing hands.

Sareum Price Performance

The business’s fifty day simple moving average is GBX 105.60 and its two-hundred day simple moving average is GBX 119.84. The company has a market cap of £66.37 million, a PE ratio of -3,250.00 and a beta of -0.53.

Insider Buying and Selling at Sareum

In related news, insider Stephen Parker bought 19,972 shares of the business’s stock in a transaction dated Wednesday, December 28th. The stock was acquired at an average price of GBX 78 ($0.95) per share, with a total value of £15,578.16 ($18,986.18). 6.40% of the stock is owned by corporate insiders.

Sareum Company Profile

(Get Rating)

Sareum Holdings plc, a specialist drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2/JAK1 kinase.

Recommended Stories

Receive News & Ratings for Sareum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sareum and related companies with's FREE daily email newsletter.